EDGAR·FLOW

MapLight Therapeutics, Inc. — Form 8-K

Filed November 16, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
MapLight Therapeutics filed an 8-K on 2026-11-16 disclosing entry into a material definitive agreement under Item 1.01. The filing provides no concrete details regarding counterparties, dollar amounts, percentages, share counts, dates, or the nature of the agreement. Exhibits referenced in the filing index are not provided in the accessible text.
Why this rating

Material agreement disclosed but zero specifics provided. Cannot assess magnitude relative to $368M asset base without terms, counterparty, or value. Routine disclosure lacking substantive detail.

Extracted items
View original filing on SEC.gov ↗ MPLT · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.